We are live on
!
Find out more
WSCM
Wellington Shields Capital Management Portfolio holdings
AUM
$788M
1-Year Est. Return
66.95%
This Fund
S&P 500
This Quarter
Est. Return
+2.55%
1 Year Est. Return
+66.95%
3 Year Est. Return
+136.75%
5 Year Est. Return
+153.04%
10 Year Est. Return
+476.57%
AUM
$831M
AUM Growth
+$7.15M
(+0.87%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
2.34%
Top 10 Holdings %
Top 10 Hldgs %
63.48%
Holding
334
New
21
Increased
86
Reduced
62
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$6.06M |
| 2 |
Apple
AAPL
|
+$4.92M |
| 3 |
Salesforce
CRM
|
+$4.34M |
| 4 |
Primerica
PRI
|
+$3.86M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$3.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$7.39M |
| 2 |
Chevron
CVX
|
+$3.25M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$2.34M |
| 4 |
Royalty Pharma
RPRX
|
+$1.9M |
| 5 |
Carlyle Group
CG
|
+$1.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 49.79% |
| 2 | Technology | 11.4% |
| 3 | Healthcare | 8.32% |
| 4 | Financials | 8.07% |
| 5 | Industrials | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Exelon
EXC
$46.2B
| – | – |
-17,000
| Closed | -$735K |
|
327
Funko
FNKO
$347M
| – | – |
-54,920
| Closed | -$599K |
|
|
328
iShares Biotechnology ETF
IBB
$9.82B
| – | – |
-17,790
| Closed | -$2.34M |
|
329
New Mountain Finance
NMFC
$732M
| – | – |
-21,000
| Closed | -$260K |
|
330
Organon & Co
OGN
$3.58B
| – | – |
-968
| Closed | -$27K |
|
331
Occidental Petroleum Corp Warrants
OXY.WS
$35.4B
| – | – |
-34
| Closed | -$1.4K |
|
|
332
Royalty Pharma
RPRX
$26B
| – | – |
-48,007
| Closed | -$1.9M |
|
333
Vanguard Consumer Discretionary ETF
VCR
$6.16B
| – | – |
-1,748
| Closed | -$383K |
|
334
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| – | – |
-350
| Closed | -$29.1K |
|
Similar funds
VH
MTWSIF
AT
AVLSA
GCM
AWG
NEAM
M
Wellington Shields Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Wellington Shields Capital Management held 334 positions worth $831M, up 0.87% from $824M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Wellington Shields Capital Management's Q1 2023 filing shows 21 new, 86 increased, 62 reduced and 14 closed positions. Its largest new stake was Ares Capital: 130,655 shares worth $2.39M. The largest sale was Johnson & Johnson, an estimated $7.39M.
By sector, the portfolio is most concentrated in Consumer Staples at 50% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
- Wellington Shields Capital Management's largest Q1 2023 buy was Ares Capital: 130,655 shares worth $2.39M.
- Wellington Shields Capital Management added most to Mastercard in Q1 2023, an estimated $6.06M increase.
- Wellington Shields Capital Management's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $7.39M.
- Wellington Shields Capital Management fully exited iShares Biotechnology ETF in Q1 2023, selling an estimated $2.34M.
- Wellington Shields Capital Management's ten largest holdings make up 63% of its $831M portfolio in Q1 2023.
- Wellington Shields Capital Management opened 21 new positions and closed 14 in Q1 2023.
- Wellington Shields Capital Management's portfolio value rose 0.87% quarter-over-quarter to $831M.
Based on Wellington Shields Capital Management's 13F filing for Q1 2023, filed 11 May 2023.